59380 Federal Register / Vol. 62, No. 212 / Monday, November 3, 1997 / Notices

11:00 a.m. Briefing on Investigative

Matters (Closed—Ex. 5 & 6)

2:00 p.m. Meeting with Commonwealth

Edison (Public Meeting) (Contact:

Bob Capra—301–415–1395)

Wednesday, November 5

9:30 a.m. Briefing on Proposed

Resolution to a Petition for

Rulemaking Relating to Use of

Potassium Iodide (KI) following

Severe Accident at a Nuclear Power

Plant (Public Meeting)

11:00 a.m. Affirmation Session (Public

Meeting)

(Please Note: These items will be affirmed

immediately following the conclusion of the

preceding meeting)

a. Final Amendments to 10 CFR Part

73, ‘‘Changes to Nuclear Power Plants

Security Requirements’’

b. Final rule on Exempt Distribution

and Use of a Radioactive Drug

Containing One Microcurie of Carbon 14

Urea (Parts 30 and 32)

Week of November 31—Tentative

There are no meetings the week of

November 10.

Week of November 17—Tentative

Friday, November 21

11:30 a.m. Affirmation Session (Public

Meeting) (if needed)

Week of November 24—Tentative

There are no meetings the week of

November 24.

ADDITIONAL INFORMATION: The

Commission meeting, ‘‘Briefing on

Staff’s Plans for 50.59 Regulatory

Process Improvements,’’ previously

scheduled on Wednesday, November 5,

has been postponed. The rescheduled

date for the meeting has not been set.

The schedule for Commission

meetings is subject to change on short

notice. To verify the status of meetings

call (Recording)—(301) 415–1292.

CONTACT PERSON FOR MORE INFORMATION:

Bill Hill (301) 415–1661.

The NRC Commission Meeting

Schedule can be found on the Internet

at:http://www.nrc.gov/SECY/smj/

schedule.htm

This notice is distributed by mail to

several hundred subscribers: if you no

longer wish to receive it, or would like

to be added to it, please contact the

Office of the Secretary, Attn: Operations

Branch, Washington, D.C. 20555 (301–

415–1661).

In addition, distribution of this

meeting notice over the Internet system

is available. If you are interested in

receiving this Commission meeting

schedule electronically, please send an

electronic message to wmh@nrc.gov or

dkw@nrc.gov.

Dated: October 29, 1997.

William M. Hill, Jr.,

Secretary Tracking Officer, Office of the

Secretary.

[FR Doc. 97–29135 Filed 10–30–97; 12:24

p.m.]

[BILLING CODE 7590–01–M]

NUCLEAR REGULATORY

COMMISSION

Workshop Notice To Solicit Public

Comments on Draft Regulatory Guide

and Standard Review Plan Section for

Risk-Informed Inservice Inspection

Programs for Piping at Nuclear Power

Plants

AGENCY: Nuclear Regulatory

Commission.

ACTION: Notice of change in date for

workshop.

SUMMARY: The Federal Register notice,

dated October 15, 1997 (Volume 62,

Number 199, page 53663) announced

the availability and solicited public

comment on drafts of a regulatory guide

and a Standard Review Plan Section for

risk-informed inservice inspection

programs for piping. These issuances

follow the Commission’s August 16,

1995 (60 FR 42622) policy statement on

the ‘‘Use of PRA Methods in Nuclear

Regulatory Activities.’’ In June 1997, the

NRC published for public comment (62

FR 34321) four draft guides, three

standard review plans and a NUREG

series document on the use of PRA in

nuclear power reactor licensing. The

NRC is developing guidance for power

reactor licensees on acceptable methods

for using probabilistic risk assessment

(PRA) information and insights in

support of plant-specific applications to

change the current licensing basis (CLB)

for inservice inspection of piping,

known as risk-informed inservice

inspection (RI–ISI) programs. The use of

such PRA information and guidance

will be voluntary. To facilitate

comment, the Commission will conduct

a workshop to explain the draft

documents and answer questions.

DATES: The workshop will be held on

November 20–21, 1997 (not on

November 19th, as announced in the

October 15, 1997, Federal Register).

Registration

There is no registration fee for this

workshop. However, we request that

interested parties register in writing to

Kesselman-Jones, 8912 James Ave., NE.,

Albuquerque, NM 87111, their intent on

participating in the workshop. Please

include name, organization, address and

phone number with your registration

request. Notification of attendance (e.g.,

pre-registration) is requested so that

adequate space, etc., for the workshop

can be arranged. Questions regarding

meeting registration or fees should be

directed to Kesselman-Jones, phone

(505) 271–0003, fax (505) 271–0482, email kessjones@aol.com.

Onsite registration begins on

November 19 at 3:00 P.M. The comment

period expires on January 13, 1997.

Comments received after this date will

be considered if it is practical to do so,

but the Commission is able to assure

consideration only for comments

received on or before this date. See the

October 15, 1997 Notice for additional

details.

Implementation

It is intended that the risk-informed

regulatory guide on inservice inspection

of piping (DG–1063), and its associated

Standard Review Plan Section 3.9.8, be

published by early to mid CY 1998.

Dated at Rockville, Maryland, this 29th day

of October 1997.

For the Nuclear Regulatory Commission.

Mark A. Cunningham,

Chief, Probabilistic Risk Analysis Branch,

Division of Systems Technology, Office of

Nuclear Regulatory Research.

[FR Doc. 97–28989 Filed 10–31–97; 8:45 am]

BILLING CODE 7590–01–P

NUCLEAR REGULATORY

COMMISSION

NRC/Nuclear Pharmacy and

Radiopharmaceutical Manufacturer

Industry—Public Workshop on the

Public Comments on Draft Regulatory

Guides DG–0006 and DG–0007

AGENCY: U.S. Nuclear Regulatory

Commission.

ACTION: Notice of meeting.

SUMMARY: The U.S. Nuclear Regulatory

Commission will be holding a public

meeting to discuss the public comments

received on two draft regulatory guides:

Draft Regulatory Guide DG–0006,

‘‘Guide for the Preparation of

Applications for Commercial Nuclear

Pharmacy Licenses,’’ and Draft

Regulatory Guide DG–0007, ‘‘Guide for

the Preparation of Applications for

Licenses to Authorize Distribution of

Various Items to Commercial Nuclear

Pharmacies and Medical Use

Licensees.’’ These documents provide

guidance to individuals applying for

commercial nuclear pharmacy and

radiopharmaceutical manufacturer

distribution licenses. Representatives of